Biosurgery Market Size, Share, Growth and Forecasts, 2016 to 2022
- Submitted by: Marketreport
- Views: 39
- Category: Other
- Date Submitted: 10/13/2016 11:43 PM
- Pages: 3
- Report this Essay
According to StratisticsMRC, the Global Biosurgery market is estimated at $15.32 billion in 2015 and is expected to reach $28.37 billion by 2022 growing at a CAGR of 9.2% from 2015 to 2022. Increasing ageing population and raise in spinal problems due to sports injuries are the key factors driving the market growth. On other hand stringent government regulations, increasing demand for minimal invasive surgeries are hampering the market. Developing health care systems in upcoming economies on account of increasing flow of funds is the opportunity to the market.
North America accounts for the largest market share followed by Europe, due to rise in obesity cases in this region. Asia Pacific and Rest of world regions are expected to grow faster due to the high investment flow and government initiatives.
Browse full report with TOC@ https://marketreportscenter.com/reports/415490/biosurgery-global-market-outlook-2016-2022
Some of the key players in the market includes B. Braun Melsungen AG, Medtronic PLC, MAQUET Holding B.V. & Co. KG., Baxter International Inc., Hemostasis, LLC, Integra Life Sciences Corporation., Johnson & Johnson, Conidian, C.R. BARD, Inc., Cryolife, Inc., Kuros Bioscience, Covidien PLC, BiomÂ’Up, Sanofi Group, Stryker Corporation, Atrium Medical Corporation and Prolife, Inc.
Applications Covered:
Thoracic Surgeries
Reconstructive Surgeries
Spinal Surgeries
Cardiovascular Surgeries
Urology Surgeries
General Surgeries
Gynecology Surgeries
Neurological Surgeries
Orthopedic Surgeries
Products Covered:
Soft-Tissue Attachments
Biological Mesh
Xenografts
Allografts
o Synthetic Mesh
Staple Line Reinforcement Agents
Hemostatic Agents
Bone Graft Subsitutes
o Bone Morphogenetic Proteins (BMP)
o Bone Allografts
o Synthetic Bone Grafts
o Demineralized Bone Matrix (DBM)
Adhesion Barriers
Surgical Sealants
o Collagen-Based Sealants
o Fibrin Sealants
o Tissue Adhesive Glues
o Synthetic Agents/Cyanoacrylates
End...
North America accounts for the largest market share followed by Europe, due to rise in obesity cases in this region. Asia Pacific and Rest of world regions are expected to grow faster due to the high investment flow and government initiatives.
Browse full report with TOC@ https://marketreportscenter.com/reports/415490/biosurgery-global-market-outlook-2016-2022
Some of the key players in the market includes B. Braun Melsungen AG, Medtronic PLC, MAQUET Holding B.V. & Co. KG., Baxter International Inc., Hemostasis, LLC, Integra Life Sciences Corporation., Johnson & Johnson, Conidian, C.R. BARD, Inc., Cryolife, Inc., Kuros Bioscience, Covidien PLC, BiomÂ’Up, Sanofi Group, Stryker Corporation, Atrium Medical Corporation and Prolife, Inc.
Applications Covered:
Thoracic Surgeries
Reconstructive Surgeries
Spinal Surgeries
Cardiovascular Surgeries
Urology Surgeries
General Surgeries
Gynecology Surgeries
Neurological Surgeries
Orthopedic Surgeries
Products Covered:
Soft-Tissue Attachments
Biological Mesh
Xenografts
Allografts
o Synthetic Mesh
Staple Line Reinforcement Agents
Hemostatic Agents
Bone Graft Subsitutes
o Bone Morphogenetic Proteins (BMP)
o Bone Allografts
o Synthetic Bone Grafts
o Demineralized Bone Matrix (DBM)
Adhesion Barriers
Surgical Sealants
o Collagen-Based Sealants
o Fibrin Sealants
o Tissue Adhesive Glues
o Synthetic Agents/Cyanoacrylates
End...